MDSCs have a variety of mechanisms used to promote tumor growth, including the expression of inducible nitric oxide synthase (iNOS), as well as the arginine-metabolizing enzyme arginase I (Arg I), both of which suppress T-cell activity and the adaptive immune response against the tumor [23,24]. This evidence concerns the gene LNCARGI and neoplasm.